A Bayesian approach for individual-level drug benefit-risk assessment

DOI10.1002/SIM.8166MaRDI QIDQ6624672zbMATH OpenFDO

Authors Kan Li, Sheng Luo, Sammy Yuan, Shahrul Mt-Isa

Publication date 28 October 2024

Published in Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

MCMClatent trait modelSMAApatient centered approach

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment
• A simple way to unify multicriteria decision analysis (MCDA) and stochastic multicriteria acceptability analysis (SMAA) using a Dirichlet distribution in benefit-risk assessment
• Dynamic Latent Trait Models for Multidimensional Longitudinal Data
• Dynamic prediction for multiple repeated measures and event time data: an application to Parkinson's disease
• MCMC using Hamiltonian dynamics
• The no-U-turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo

This page was built for publication: A Bayesian approach for individual-level drug benefit-risk assessment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6624672)